Literature DB >> 10935542

Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation.

M A Rycyzyn1, S C Reilly, K O'Malley, C V Clevenger.   

Abstract

The pleiotropic actions of PRL are necessary for mammary growth and differentiation and in vitro lymphoid proliferation. The proximal action of this ligand is mediated by its cell surface receptor via associated networks. PRL action, however, is also associated with the internalization and translocation of this hormone into the nucleus. To delineate the mechanism of this retrotranslocation, a yeast two-hybrid screen was performed and revealed an interaction between PRL and cyclophilin B (CypB). CypB is a peptidyl prolyl isomerase (PPI) found in the endoplasmic reticulum, extracellular space, and nucleus. The interaction between CypB and PRL was subsequently confirmed in vitro and in vivo through the use of recombinant proteins and coimmunoprecipitation studies. The exogenous addition of CypB potentiated the 3H-thymidine incorporation of PRL-dependent cell lines up to 18-fold. CypB by itself was nonmitogenic and did not potentiate the action of GH or other interleukins. CypB did not alter the affinity of the PRL receptor (PRLr) for its ligand, or increase the phosphorylation of PRLr-associated Jak2 or Stat5a. The potentiation of PRL-action by CypB, however, was accompanied by a dramatic increase in the nuclear retrotranslocation of PRL. A CypB mutant, termed CypB-NT, was generated that lacked the wild-type N-terminal nuclear localization sequence. Although CypB-NT demonstrated levels of PRL binding and PPI activity equivalent to wild-type CypB, it was incapable of mediating the nuclear retrotranslocation of PRL or enhancing PRL-driven proliferation. These studies reveal CypB as an important chaperone facilitating the nuclear retrotransport and action of the lactogenic hormones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935542     DOI: 10.1210/mend.14.8.0508

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

1.  Genetic selection for modulators of a retinoic-acid-responsive reporter in human cells.

Authors:  Burt Richards; Jon Karpilow; Christine Dunn; Isaac Peterson; Andrew Maxfield; Ludmilla Zharkikh; Majid Abedi; Anthony Hurlburt; Joshua Hardman; Forrest Hsu; Wenhua Li; Matthew Rebentisch; Robert Sandrock; Tanya Sandrock; Alexander Kamb; David H-F Teng
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

2.  Characterization of nuclear neurokinin 3 receptor expression in rat brain.

Authors:  C D Sladek; W Stevens; S R Levinson; Z Song; D D Jensen; F W Flynn
Journal:  Neuroscience       Date:  2011-09-08       Impact factor: 3.590

3.  Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Authors:  Feng Fang; Jiamao Zheng; Traci L Galbaugh; Alyson A Fiorillo; Elizabeth E Hjort; Xianke Zeng; Charles V Clevenger
Journal:  J Mol Endocrinol       Date:  2010-03-17       Impact factor: 5.098

4.  Research Resource: A Dual Proteomic Approach Identifies Regulated Islet Proteins During β-Cell Mass Expansion In Vivo.

Authors:  Signe Horn; Jeannette S Kirkegaard; Soraya Hoelper; Philip A Seymour; Claude Rescan; Jens H Nielsen; Ole D Madsen; Jan N Jensen; Marcus Krüger; Mads Grønborg; Jonas Ahnfelt-Rønne
Journal:  Mol Endocrinol       Date:  2015-12-09

Review 5.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Defining suitable reference genes for RT-qPCR analysis on intestinal epithelial cells.

Authors:  Maria Sirakov; Marco Borra; Francesca Maria Cambuli; Michelina Plateroti
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

Review 7.  Management of cytoskeleton architecture by molecular chaperones and immunophilins.

Authors:  Héctor R Quintá; Natalia M Galigniana; Alejandra G Erlejman; Mariana Lagadari; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  Cell Signal       Date:  2011-08-12       Impact factor: 4.315

8.  Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

Authors:  John F Langenheim; Wen Y Chen
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

9.  Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer.

Authors:  Feng Fang; Ayanna J Flegler; Pan Du; Simon Lin; Charles V Clevenger
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

10.  Severe osteogenesis imperfecta in cyclophilin B-deficient mice.

Authors:  Jae Won Choi; Shari L Sutor; Lonn Lindquist; Glenda L Evans; Benjamin J Madden; H Robert Bergen; Theresa E Hefferan; Michael J Yaszemski; Richard J Bram
Journal:  PLoS Genet       Date:  2009-12-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.